{"id":157352,"date":"2023-12-14T07:57:44","date_gmt":"2023-12-14T12:57:44","guid":{"rendered":"https:\/\/44.250.171.167\/?p=157352"},"modified":"2023-12-14T07:57:46","modified_gmt":"2023-12-14T12:57:46","slug":"life-sciences-ltd-q2fy24-25-fall-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/life-sciences-ltd-q2fy24-25-fall-in-revenue\/","title":{"rendered":"Life Sciences Ltd Q2FY24; 25% fall in Revenue"},"content":{"rendered":"\n<p>Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Suven Life Sciences Ltd reported Revenues for Q2FY24 of \u20b93.00 Crores down from \u20b94.00 Crore year on year, a fall of 25.0%.<\/p>\n\n\n\n<p>Total Expenses for Q2FY24 of \u20b929.00 Crores up from \u20b928.00 Crores year on year, a rise of 3.57%.<\/p>\n\n\n\n<p>Consolidated Net Profit of -\u20b913.00 Crores from -\u20b923.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is -\u20b90.58, from -\u20b91.06 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111-839x1024.png\" alt=\"\" class=\"wp-image-157353\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/app.asai.alphastreet.io\/test-drive\/dashboard?utm_source=IN_WordPress&amp;utm_medium=IN_WordPress&amp;utm_campaign=IN_WordPress&amp;utm_id=IN_WordPress\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"321\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/ASAI-Product-2-3.gif\" alt=\"\" class=\"wp-image-157333\"\/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q2FY24 of \u20b93.00 Crores down from \u20b94.00 Crore year on year, a fall of 25.0%. Total Expenses for Q2FY24 of \u20b929.00 [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":157353,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[3059,12689,12688],"class_list":["post-157352","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-biopharma","tag-neurogenerative","tag-therapeutics"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":156068,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q2fy24-11-rise-in-profits\/","url_meta":{"origin":157352,"position":0},"title":"Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits","author":"Chirag Gupta","date":"November 10, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b9231.00 Crores down from \u20b9278.00 Crore year on year, a fall of 16.91%. Total Expenses for Q2FY24 of \u20b9145.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169131,"url":"https:\/\/alphastreet.com\/india\/suven-life-sciences-ltd-q4fy25-50-fall-in-revenue\/","url_meta":{"origin":157352,"position":1},"title":"Suven Life Sciences Ltd Q4FY25; 50% fall in Revenue","author":"Chirag Gupta","date":"July 14, 2025","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q4FY25 of \u20b91.00 Crores down from \u20b92.00 Crore year on year, a fall of 50.0%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151736,"url":"https:\/\/alphastreet.com\/india\/suven-life-sciences-ltd-q1fy24-0-equalled-in-revenue\/","url_meta":{"origin":157352,"position":2},"title":"Suven Life Sciences Ltd Q1FY24; 0% equalled in Revenue","author":"Chirag Gupta","date":"August 8, 2023","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q1FY24 of \u20b94.00 Crores same from \u20b94.00 Crore year on year. Total Expenses for Q1FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170125,"url":"https:\/\/alphastreet.com\/india\/suven-life-sciences-q1-fy26-earnings-results\/","url_meta":{"origin":157352,"position":3},"title":"Suven Life Sciences Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 13, 2025","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. The company has been working towards developing new molecules\/ compounds in the complex CNS (central nervous system) space. Most of its lead molecules address the\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Suven Life Sciences Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156671,"url":"https:\/\/alphastreet.com\/india\/camlin-fine-sciences-ltd-q2fy24-16-fall-in-revenue\/","url_meta":{"origin":157352,"position":4},"title":"Camlin Fine Sciences Ltd Q2FY24; 16% fall in Revenue","author":"Divyansh_Kasana","date":"November 27, 2023","format":false,"excerpt":"Camlin Fine Sciences is engaged in the Business of Speciality Chemicals. Financial Results: Camlin Fine Sciences Ltd reported Revenues for Q2FY24 of \u20b9406.00 Crores down from \u20b9483.00 Crore year on year, a fall of 15.94%. Total Expenses for Q2FY24 of \u20b9420.00 Crores down from \u20b9460.00 Crores year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-331.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157279,"url":"https:\/\/alphastreet.com\/india\/solara-active-pharma-sciences-ltd-q2fy24-26-rise-in-revenue\/","url_meta":{"origin":157352,"position":5},"title":"Solara Active Pharma Sciences Ltd Q2FY24; 26% rise in Revenue","author":"Chirag Gupta","date":"December 12, 2023","format":false,"excerpt":"Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. Financial Results: Solara Active Pharma Sciences Ltd reported Revenues for Q2FY24 of \u20b9425.00 Crores up from \u20b9338.00 Crore year on year, a rise of 25.74%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/157352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=157352"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/157352\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/157353"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=157352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=157352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=157352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}